Global Anti-GFP Nanobody Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Anti-GFP nanobody is a single-domain antibody specifically targeting green fluorescent protein (GFP), usually derived from camelids. Since GFP and its derivatives are widely used for labeling and tracking in biological research, anti-GFP nanobody has become an important part of research tools.
The global Anti-GFP Nanobody market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Anti-GFP Nanobody Industry Forecast” looks at past sales and reviews total world Anti-GFP Nanobody sales in 2023, providing a comprehensive analysis by region and market sector of projected Anti-GFP Nanobody sales for 2024 through 2030. With Anti-GFP Nanobody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-GFP Nanobody industry.
This Insight Report provides a comprehensive analysis of the global Anti-GFP Nanobody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-GFP Nanobody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-GFP Nanobody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-GFP Nanobody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-GFP Nanobody.
United States market for Anti-GFP Nanobody is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Anti-GFP Nanobody is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Anti-GFP Nanobody is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Anti-GFP Nanobody players cover Sino Biological, GenScript, Proteintech Group, Abiocenter, MerryBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-GFP Nanobody market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Anti-GFP Nanobody market?
What factors are driving Anti-GFP Nanobody market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-GFP Nanobody market opportunities vary by end market size?
How does Anti-GFP Nanobody break out by Type, by Application?
Anti-GFP nanobody is a single-domain antibody specifically targeting green fluorescent protein (GFP), usually derived from camelids. Since GFP and its derivatives are widely used for labeling and tracking in biological research, anti-GFP nanobody has become an important part of research tools.
The global Anti-GFP Nanobody market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Anti-GFP Nanobody Industry Forecast” looks at past sales and reviews total world Anti-GFP Nanobody sales in 2023, providing a comprehensive analysis by region and market sector of projected Anti-GFP Nanobody sales for 2024 through 2030. With Anti-GFP Nanobody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-GFP Nanobody industry.
This Insight Report provides a comprehensive analysis of the global Anti-GFP Nanobody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-GFP Nanobody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-GFP Nanobody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-GFP Nanobody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-GFP Nanobody.
United States market for Anti-GFP Nanobody is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Anti-GFP Nanobody is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Anti-GFP Nanobody is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Anti-GFP Nanobody players cover Sino Biological, GenScript, Proteintech Group, Abiocenter, MerryBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-GFP Nanobody market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Monovalent Nanobodies
- Bivalent Nanobodies
- Bispecific Nanobodies
- Multivalent Nanobodies
- Fused Nanobodies
- Immunoprecipitation
- Chromatin Immunoprecipitation
- RNA Binding Protein Immunoprecipitation
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sino Biological
- GenScript
- Proteintech Group
- Abiocenter
- MerryBio
- Pregene
- Cusabio
- Biocytogen
- Thermo Fisher Scientific
- QVQuality
- HUABIO
- Jackson ImmunoResearch
What is the 10-year outlook for the global Anti-GFP Nanobody market?
What factors are driving Anti-GFP Nanobody market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-GFP Nanobody market opportunities vary by end market size?
How does Anti-GFP Nanobody break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-GFP Nanobody Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Anti-GFP Nanobody by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Anti-GFP Nanobody by Country/Region, 2019, 2023 & 2030
2.2 Anti-GFP Nanobody Segment by Type
2.2.1 Monovalent Nanobodies
2.2.2 Bivalent Nanobodies
2.2.3 Bispecific Nanobodies
2.2.4 Multivalent Nanobodies
2.2.5 Fused Nanobodies
2.3 Anti-GFP Nanobody Sales by Type
2.3.1 Global Anti-GFP Nanobody Sales Market Share by Type (2019-2024)
2.3.2 Global Anti-GFP Nanobody Revenue and Market Share by Type (2019-2024)
2.3.3 Global Anti-GFP Nanobody Sale Price by Type (2019-2024)
2.4 Anti-GFP Nanobody Segment by Application
2.4.1 Immunoprecipitation
2.4.2 Chromatin Immunoprecipitation
2.4.3 RNA Binding Protein Immunoprecipitation
2.4.4 Other
2.5 Anti-GFP Nanobody Sales by Application
2.5.1 Global Anti-GFP Nanobody Sale Market Share by Application (2019-2024)
2.5.2 Global Anti-GFP Nanobody Revenue and Market Share by Application (2019-2024)
2.5.3 Global Anti-GFP Nanobody Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Anti-GFP Nanobody Breakdown Data by Company
3.1.1 Global Anti-GFP Nanobody Annual Sales by Company (2019-2024)
3.1.2 Global Anti-GFP Nanobody Sales Market Share by Company (2019-2024)
3.2 Global Anti-GFP Nanobody Annual Revenue by Company (2019-2024)
3.2.1 Global Anti-GFP Nanobody Revenue by Company (2019-2024)
3.2.2 Global Anti-GFP Nanobody Revenue Market Share by Company (2019-2024)
3.3 Global Anti-GFP Nanobody Sale Price by Company
3.4 Key Manufacturers Anti-GFP Nanobody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-GFP Nanobody Product Location Distribution
3.4.2 Players Anti-GFP Nanobody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-GFP NANOBODY BY GEOGRAPHIC REGION
4.1 World Historic Anti-GFP Nanobody Market Size by Geographic Region (2019-2024)
4.1.1 Global Anti-GFP Nanobody Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Anti-GFP Nanobody Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Anti-GFP Nanobody Market Size by Country/Region (2019-2024)
4.2.1 Global Anti-GFP Nanobody Annual Sales by Country/Region (2019-2024)
4.2.2 Global Anti-GFP Nanobody Annual Revenue by Country/Region (2019-2024)
4.3 Americas Anti-GFP Nanobody Sales Growth
4.4 APAC Anti-GFP Nanobody Sales Growth
4.5 Europe Anti-GFP Nanobody Sales Growth
4.6 Middle East & Africa Anti-GFP Nanobody Sales Growth
5 AMERICAS
5.1 Americas Anti-GFP Nanobody Sales by Country
5.1.1 Americas Anti-GFP Nanobody Sales by Country (2019-2024)
5.1.2 Americas Anti-GFP Nanobody Revenue by Country (2019-2024)
5.2 Americas Anti-GFP Nanobody Sales by Type (2019-2024)
5.3 Americas Anti-GFP Nanobody Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-GFP Nanobody Sales by Region
6.1.1 APAC Anti-GFP Nanobody Sales by Region (2019-2024)
6.1.2 APAC Anti-GFP Nanobody Revenue by Region (2019-2024)
6.2 APAC Anti-GFP Nanobody Sales by Type (2019-2024)
6.3 APAC Anti-GFP Nanobody Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-GFP Nanobody by Country
7.1.1 Europe Anti-GFP Nanobody Sales by Country (2019-2024)
7.1.2 Europe Anti-GFP Nanobody Revenue by Country (2019-2024)
7.2 Europe Anti-GFP Nanobody Sales by Type (2019-2024)
7.3 Europe Anti-GFP Nanobody Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-GFP Nanobody by Country
8.1.1 Middle East & Africa Anti-GFP Nanobody Sales by Country (2019-2024)
8.1.2 Middle East & Africa Anti-GFP Nanobody Revenue by Country (2019-2024)
8.2 Middle East & Africa Anti-GFP Nanobody Sales by Type (2019-2024)
8.3 Middle East & Africa Anti-GFP Nanobody Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-GFP Nanobody
10.3 Manufacturing Process Analysis of Anti-GFP Nanobody
10.4 Industry Chain Structure of Anti-GFP Nanobody
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-GFP Nanobody Distributors
11.3 Anti-GFP Nanobody Customer
12 WORLD FORECAST REVIEW FOR ANTI-GFP NANOBODY BY GEOGRAPHIC REGION
12.1 Global Anti-GFP Nanobody Market Size Forecast by Region
12.1.1 Global Anti-GFP Nanobody Forecast by Region (2025-2030)
12.1.2 Global Anti-GFP Nanobody Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Anti-GFP Nanobody Forecast by Type (2025-2030)
12.7 Global Anti-GFP Nanobody Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Sino Biological
13.1.1 Sino Biological Company Information
13.1.2 Sino Biological Anti-GFP Nanobody Product Portfolios and Specifications
13.1.3 Sino Biological Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sino Biological Main Business Overview
13.1.5 Sino Biological Latest Developments
13.2 GenScript
13.2.1 GenScript Company Information
13.2.2 GenScript Anti-GFP Nanobody Product Portfolios and Specifications
13.2.3 GenScript Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GenScript Main Business Overview
13.2.5 GenScript Latest Developments
13.3 Proteintech Group
13.3.1 Proteintech Group Company Information
13.3.2 Proteintech Group Anti-GFP Nanobody Product Portfolios and Specifications
13.3.3 Proteintech Group Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Proteintech Group Main Business Overview
13.3.5 Proteintech Group Latest Developments
13.4 Abiocenter
13.4.1 Abiocenter Company Information
13.4.2 Abiocenter Anti-GFP Nanobody Product Portfolios and Specifications
13.4.3 Abiocenter Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Abiocenter Main Business Overview
13.4.5 Abiocenter Latest Developments
13.5 MerryBio
13.5.1 MerryBio Company Information
13.5.2 MerryBio Anti-GFP Nanobody Product Portfolios and Specifications
13.5.3 MerryBio Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 MerryBio Main Business Overview
13.5.5 MerryBio Latest Developments
13.6 Pregene
13.6.1 Pregene Company Information
13.6.2 Pregene Anti-GFP Nanobody Product Portfolios and Specifications
13.6.3 Pregene Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Pregene Main Business Overview
13.6.5 Pregene Latest Developments
13.7 Cusabio
13.7.1 Cusabio Company Information
13.7.2 Cusabio Anti-GFP Nanobody Product Portfolios and Specifications
13.7.3 Cusabio Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Cusabio Main Business Overview
13.7.5 Cusabio Latest Developments
13.8 Biocytogen
13.8.1 Biocytogen Company Information
13.8.2 Biocytogen Anti-GFP Nanobody Product Portfolios and Specifications
13.8.3 Biocytogen Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Biocytogen Main Business Overview
13.8.5 Biocytogen Latest Developments
13.9 Thermo Fisher Scientific
13.9.1 Thermo Fisher Scientific Company Information
13.9.2 Thermo Fisher Scientific Anti-GFP Nanobody Product Portfolios and Specifications
13.9.3 Thermo Fisher Scientific Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Thermo Fisher Scientific Main Business Overview
13.9.5 Thermo Fisher Scientific Latest Developments
13.10 QVQuality
13.10.1 QVQuality Company Information
13.10.2 QVQuality Anti-GFP Nanobody Product Portfolios and Specifications
13.10.3 QVQuality Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 QVQuality Main Business Overview
13.10.5 QVQuality Latest Developments
13.11 HUABIO
13.11.1 HUABIO Company Information
13.11.2 HUABIO Anti-GFP Nanobody Product Portfolios and Specifications
13.11.3 HUABIO Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 HUABIO Main Business Overview
13.11.5 HUABIO Latest Developments
13.12 Jackson ImmunoResearch
13.12.1 Jackson ImmunoResearch Company Information
13.12.2 Jackson ImmunoResearch Anti-GFP Nanobody Product Portfolios and Specifications
13.12.3 Jackson ImmunoResearch Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Jackson ImmunoResearch Main Business Overview
13.12.5 Jackson ImmunoResearch Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Anti-GFP Nanobody Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Anti-GFP Nanobody Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Monovalent Nanobodies
Table 4. Major Players of Bivalent Nanobodies
Table 5. Major Players of Bispecific Nanobodies
Table 6. Major Players of Multivalent Nanobodies
Table 7. Major Players ofFused Nanobodies
Table 8. Global Anti-GFP Nanobody Sales byType (2019-2024) & (K Units)
Table 9. Global Anti-GFP Nanobody Sales Market Share byType (2019-2024)
Table 10. Global Anti-GFP Nanobody Revenue byType (2019-2024) & ($ million)
Table 11. Global Anti-GFP Nanobody Revenue Market Share byType (2019-2024)
Table 12. Global Anti-GFP Nanobody Sale Price byType (2019-2024) & (US$/Unit)
Table 13. Global Anti-GFP Nanobody Sale by Application (2019-2024) & (K Units)
Table 14. Global Anti-GFP Nanobody Sale Market Share by Application (2019-2024)
Table 15. Global Anti-GFP Nanobody Revenue by Application (2019-2024) & ($ million)
Table 16. Global Anti-GFP Nanobody Revenue Market Share by Application (2019-2024)
Table 17. Global Anti-GFP Nanobody Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global Anti-GFP Nanobody Sales by Company (2019-2024) & (K Units)
Table 19. Global Anti-GFP Nanobody Sales Market Share by Company (2019-2024)
Table 20. Global Anti-GFP Nanobody Revenue by Company (2019-2024) & ($ millions)
Table 21. Global Anti-GFP Nanobody Revenue Market Share by Company (2019-2024)
Table 22. Global Anti-GFP Nanobody Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers Anti-GFP Nanobody Producing Area Distribution and Sales Area
Table 24. Players Anti-GFP Nanobody Products Offered
Table 25. Anti-GFP Nanobody Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Anti-GFP Nanobody Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Anti-GFP Nanobody Sales Market Share Geographic Region (2019-2024)
Table 30. Global Anti-GFP Nanobody Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Anti-GFP Nanobody Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Anti-GFP Nanobody Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Anti-GFP Nanobody Sales Market Share by Country/Region (2019-2024)
Table 34. Global Anti-GFP Nanobody Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Anti-GFP Nanobody Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Anti-GFP Nanobody Sales by Country (2019-2024) & (K Units)
Table 37. Americas Anti-GFP Nanobody Sales Market Share by Country (2019-2024)
Table 38. Americas Anti-GFP Nanobody Revenue by Country (2019-2024) & ($ millions)
Table 39. Americas Anti-GFP Nanobody Sales byType (2019-2024) & (K Units)
Table 40. Americas Anti-GFP Nanobody Sales by Application (2019-2024) & (K Units)
Table 41. APAC Anti-GFP Nanobody Sales by Region (2019-2024) & (K Units)
Table 42. APAC Anti-GFP Nanobody Sales Market Share by Region (2019-2024)
Table 43. APAC Anti-GFP Nanobody Revenue by Region (2019-2024) & ($ millions)
Table 44. APAC Anti-GFP Nanobody Sales byType (2019-2024) & (K Units)
Table 45. APAC Anti-GFP Nanobody Sales by Application (2019-2024) & (K Units)
Table 46. Europe Anti-GFP Nanobody Sales by Country (2019-2024) & (K Units)
Table 47. Europe Anti-GFP Nanobody Revenue by Country (2019-2024) & ($ millions)
Table 48. Europe Anti-GFP Nanobody Sales byType (2019-2024) & (K Units)
Table 49. Europe Anti-GFP Nanobody Sales by Application (2019-2024) & (K Units)
Table 50. Middle East & Africa Anti-GFP Nanobody Sales by Country (2019-2024) & (K Units)
Table 51. Middle East & Africa Anti-GFP Nanobody Revenue Market Share by Country (2019-2024)
Table 52. Middle East & Africa Anti-GFP Nanobody Sales byType (2019-2024) & (K Units)
Table 53. Middle East & Africa Anti-GFP Nanobody Sales by Application (2019-2024) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Anti-GFP Nanobody
Table 55. Key Market Challenges & Risks of Anti-GFP Nanobody
Table 56. Key IndustryTrends of Anti-GFP Nanobody
Table 57. Anti-GFP Nanobody Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Anti-GFP Nanobody Distributors List
Table 60. Anti-GFP Nanobody Customer List
Table 61. Global Anti-GFP Nanobody SalesForecast by Region (2025-2030) & (K Units)
Table 62. Global Anti-GFP Nanobody RevenueForecast by Region (2025-2030) & ($ millions)
Table 63. Americas Anti-GFP Nanobody SalesForecast by Country (2025-2030) & (K Units)
Table 64. Americas Anti-GFP Nanobody Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 65. APAC Anti-GFP Nanobody SalesForecast by Region (2025-2030) & (K Units)
Table 66. APAC Anti-GFP Nanobody Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 67. Europe Anti-GFP Nanobody SalesForecast by Country (2025-2030) & (K Units)
Table 68. Europe Anti-GFP Nanobody RevenueForecast by Country (2025-2030) & ($ millions)
Table 69. Middle East & Africa Anti-GFP Nanobody SalesForecast by Country (2025-2030) & (K Units)
Table 70. Middle East & Africa Anti-GFP Nanobody RevenueForecast by Country (2025-2030) & ($ millions)
Table 71. Global Anti-GFP Nanobody SalesForecast byType (2025-2030) & (K Units)
Table 72. Global Anti-GFP Nanobody RevenueForecast byType (2025-2030) & ($ millions)
Table 73. Global Anti-GFP Nanobody SalesForecast by Application (2025-2030) & (K Units)
Table 74. Global Anti-GFP Nanobody RevenueForecast by Application (2025-2030) & ($ millions)
Table 75. Sino Biological Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 76. Sino Biological Anti-GFP Nanobody Product Portfolios and Specifications
Table 77. Sino Biological Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sino Biological Main Business
Table 79. Sino Biological Latest Developments
Table 80. GenScript Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 81. GenScript Anti-GFP Nanobody Product Portfolios and Specifications
Table 82. GenScript Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. GenScript Main Business
Table 84. GenScript Latest Developments
Table 85. Proteintech Group Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 86. Proteintech Group Anti-GFP Nanobody Product Portfolios and Specifications
Table 87. Proteintech Group Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Proteintech Group Main Business
Table 89. Proteintech Group Latest Developments
Table 90. Abiocenter Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 91. Abiocenter Anti-GFP Nanobody Product Portfolios and Specifications
Table 92. Abiocenter Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Abiocenter Main Business
Table 94. Abiocenter Latest Developments
Table 95. MerryBio Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 96. MerryBio Anti-GFP Nanobody Product Portfolios and Specifications
Table 97. MerryBio Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. MerryBio Main Business
Table 99. MerryBio Latest Developments
Table 100. Pregene Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 101. Pregene Anti-GFP Nanobody Product Portfolios and Specifications
Table 102. Pregene Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Pregene Main Business
Table 104. Pregene Latest Developments
Table 105. Cusabio Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 106. Cusabio Anti-GFP Nanobody Product Portfolios and Specifications
Table 107. Cusabio Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Cusabio Main Business
Table 109. Cusabio Latest Developments
Table 110. Biocytogen Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 111. Biocytogen Anti-GFP Nanobody Product Portfolios and Specifications
Table 112. Biocytogen Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Biocytogen Main Business
Table 114. Biocytogen Latest Developments
Table 115.ThermoFisher Scientific Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 116.ThermoFisher Scientific Anti-GFP Nanobody Product Portfolios and Specifications
Table 117.ThermoFisher Scientific Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118.ThermoFisher Scientific Main Business
Table 119.ThermoFisher Scientific Latest Developments
Table 120. QVQuality Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 121. QVQuality Anti-GFP Nanobody Product Portfolios and Specifications
Table 122. QVQuality Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. QVQuality Main Business
Table 124. QVQuality Latest Developments
Table 125. HUABIO Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 126. HUABIO Anti-GFP Nanobody Product Portfolios and Specifications
Table 127. HUABIO Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. HUABIO Main Business
Table 129. HUABIO Latest Developments
Table 130. Jackson ImmunoResearch Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 131. Jackson ImmunoResearch Anti-GFP Nanobody Product Portfolios and Specifications
Table 132. Jackson ImmunoResearch Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Jackson ImmunoResearch Main Business
Table 134. Jackson ImmunoResearch Latest Developments
LIST OFFIGURES
Figure 1. Picture of Anti-GFP Nanobody
Figure 2. Anti-GFP Nanobody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-GFP Nanobody Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Anti-GFP Nanobody Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Anti-GFP Nanobody Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Anti-GFP Nanobody Sales Market Share by Country/Region (2023)
Figure 10. Anti-GFP Nanobody Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Monovalent Nanobodies
Figure 12. Product Picture of Bivalent Nanobodies
Figure 13. Product Picture of Bispecific Nanobodies
Figure 14. Product Picture of Multivalent Nanobodies
Figure 15. Product Picture ofFused Nanobodies
Figure 16. Global Anti-GFP Nanobody Sales Market Share byType in 2023
Figure 17. Global Anti-GFP Nanobody Revenue Market Share byType (2019-2024)
Figure 18. Anti-GFP Nanobody Consumed in Immunoprecipitation
Figure 19. Global Anti-GFP Nanobody Market: Immunoprecipitation (2019-2024) & (K Units)
Figure 20. Anti-GFP Nanobody Consumed in Chromatin Immunoprecipitation
Figure 21. Global Anti-GFP Nanobody Market: Chromatin Immunoprecipitation (2019-2024) & (K Units)
Figure 22. Anti-GFP Nanobody Consumed in RNA Binding Protein Immunoprecipitation
Figure 23. Global Anti-GFP Nanobody Market: RNA Binding Protein Immunoprecipitation (2019-2024) & (K Units)
Figure 24. Anti-GFP Nanobody Consumed in Other
Figure 25. Global Anti-GFP Nanobody Market: Other (2019-2024) & (K Units)
Figure 26. Global Anti-GFP Nanobody Sale Market Share by Application (2023)
Figure 27. Global Anti-GFP Nanobody Revenue Market Share by Application in 2023
Figure 28. Anti-GFP Nanobody Sales by Company in 2023 (K Units)
Figure 29. Global Anti-GFP Nanobody Sales Market Share by Company in 2023
Figure 30. Anti-GFP Nanobody Revenue by Company in 2023 ($ millions)
Figure 31. Global Anti-GFP Nanobody Revenue Market Share by Company in 2023
Figure 32. Global Anti-GFP Nanobody Sales Market Share by Geographic Region (2019-2024)
Figure 33. Global Anti-GFP Nanobody Revenue Market Share by Geographic Region in 2023
Figure 34. Americas Anti-GFP Nanobody Sales 2019-2024 (K Units)
Figure 35. Americas Anti-GFP Nanobody Revenue 2019-2024 ($ millions)
Figure 36. APAC Anti-GFP Nanobody Sales 2019-2024 (K Units)
Figure 37. APAC Anti-GFP Nanobody Revenue 2019-2024 ($ millions)
Figure 38. Europe Anti-GFP Nanobody Sales 2019-2024 (K Units)
Figure 39. Europe Anti-GFP Nanobody Revenue 2019-2024 ($ millions)
Figure 40. Middle East & Africa Anti-GFP Nanobody Sales 2019-2024 (K Units)
Figure 41. Middle East & Africa Anti-GFP Nanobody Revenue 2019-2024 ($ millions)
Figure 42. Americas Anti-GFP Nanobody Sales Market Share by Country in 2023
Figure 43. Americas Anti-GFP Nanobody Revenue Market Share by Country (2019-2024)
Figure 44. Americas Anti-GFP Nanobody Sales Market Share byType (2019-2024)
Figure 45. Americas Anti-GFP Nanobody Sales Market Share by Application (2019-2024)
Figure 46. United States Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 47. Canada Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 48. Mexico Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 49. Brazil Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 50. APAC Anti-GFP Nanobody Sales Market Share by Region in 2023
Figure 51. APAC Anti-GFP Nanobody Revenue Market Share by Region (2019-2024)
Figure 52. APAC Anti-GFP Nanobody Sales Market Share byType (2019-2024)
Figure 53. APAC Anti-GFP Nanobody Sales Market Share by Application (2019-2024)
Figure 54. China Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 55. Japan Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 56. South Korea Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 57. Southeast Asia Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 58. India Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 59. Australia Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 60. ChinaTaiwan Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 61. Europe Anti-GFP Nanobody Sales Market Share by Country in 2023
Figure 62. Europe Anti-GFP Nanobody Revenue Market Share by Country (2019-2024)
Figure 63. Europe Anti-GFP Nanobody Sales Market Share byType (2019-2024)
Figure 64. Europe Anti-GFP Nanobody Sales Market Share by Application (2019-2024)
Figure 65. Germany Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 66.France Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 67. UK Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 68. Italy Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 69. Russia Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 70. Middle East & Africa Anti-GFP Nanobody Sales Market Share by Country (2019-2024)
Figure 71. Middle East & Africa Anti-GFP Nanobody Sales Market Share byType (2019-2024)
Figure 72. Middle East & Africa Anti-GFP Nanobody Sales Market Share by Application (2019-2024)
Figure 73. Egypt Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 74. South Africa Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 75. Israel Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 76.Turkey Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 77. GCC Countries Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Anti-GFP Nanobody in 2023
Figure 79. Manufacturing Process Analysis of Anti-GFP Nanobody
Figure 80. Industry Chain Structure of Anti-GFP Nanobody
Figure 81. Channels of Distribution
Figure 82. Global Anti-GFP Nanobody Sales MarketForecast by Region (2025-2030)
Figure 83. Global Anti-GFP Nanobody Revenue Market ShareForecast by Region (2025-2030)
Figure 84. Global Anti-GFP Nanobody Sales Market ShareForecast byType (2025-2030)
Figure 85. Global Anti-GFP Nanobody Revenue Market ShareForecast byType (2025-2030)
Figure 86. Global Anti-GFP Nanobody Sales Market ShareForecast by Application (2025-2030)
Figure 87. Global Anti-GFP Nanobody Revenue Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-GFP Nanobody Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Anti-GFP Nanobody by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Anti-GFP Nanobody by Country/Region, 2019, 2023 & 2030
2.2 Anti-GFP Nanobody Segment by Type
2.2.1 Monovalent Nanobodies
2.2.2 Bivalent Nanobodies
2.2.3 Bispecific Nanobodies
2.2.4 Multivalent Nanobodies
2.2.5 Fused Nanobodies
2.3 Anti-GFP Nanobody Sales by Type
2.3.1 Global Anti-GFP Nanobody Sales Market Share by Type (2019-2024)
2.3.2 Global Anti-GFP Nanobody Revenue and Market Share by Type (2019-2024)
2.3.3 Global Anti-GFP Nanobody Sale Price by Type (2019-2024)
2.4 Anti-GFP Nanobody Segment by Application
2.4.1 Immunoprecipitation
2.4.2 Chromatin Immunoprecipitation
2.4.3 RNA Binding Protein Immunoprecipitation
2.4.4 Other
2.5 Anti-GFP Nanobody Sales by Application
2.5.1 Global Anti-GFP Nanobody Sale Market Share by Application (2019-2024)
2.5.2 Global Anti-GFP Nanobody Revenue and Market Share by Application (2019-2024)
2.5.3 Global Anti-GFP Nanobody Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Anti-GFP Nanobody Breakdown Data by Company
3.1.1 Global Anti-GFP Nanobody Annual Sales by Company (2019-2024)
3.1.2 Global Anti-GFP Nanobody Sales Market Share by Company (2019-2024)
3.2 Global Anti-GFP Nanobody Annual Revenue by Company (2019-2024)
3.2.1 Global Anti-GFP Nanobody Revenue by Company (2019-2024)
3.2.2 Global Anti-GFP Nanobody Revenue Market Share by Company (2019-2024)
3.3 Global Anti-GFP Nanobody Sale Price by Company
3.4 Key Manufacturers Anti-GFP Nanobody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-GFP Nanobody Product Location Distribution
3.4.2 Players Anti-GFP Nanobody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-GFP NANOBODY BY GEOGRAPHIC REGION
4.1 World Historic Anti-GFP Nanobody Market Size by Geographic Region (2019-2024)
4.1.1 Global Anti-GFP Nanobody Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Anti-GFP Nanobody Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Anti-GFP Nanobody Market Size by Country/Region (2019-2024)
4.2.1 Global Anti-GFP Nanobody Annual Sales by Country/Region (2019-2024)
4.2.2 Global Anti-GFP Nanobody Annual Revenue by Country/Region (2019-2024)
4.3 Americas Anti-GFP Nanobody Sales Growth
4.4 APAC Anti-GFP Nanobody Sales Growth
4.5 Europe Anti-GFP Nanobody Sales Growth
4.6 Middle East & Africa Anti-GFP Nanobody Sales Growth
5 AMERICAS
5.1 Americas Anti-GFP Nanobody Sales by Country
5.1.1 Americas Anti-GFP Nanobody Sales by Country (2019-2024)
5.1.2 Americas Anti-GFP Nanobody Revenue by Country (2019-2024)
5.2 Americas Anti-GFP Nanobody Sales by Type (2019-2024)
5.3 Americas Anti-GFP Nanobody Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-GFP Nanobody Sales by Region
6.1.1 APAC Anti-GFP Nanobody Sales by Region (2019-2024)
6.1.2 APAC Anti-GFP Nanobody Revenue by Region (2019-2024)
6.2 APAC Anti-GFP Nanobody Sales by Type (2019-2024)
6.3 APAC Anti-GFP Nanobody Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-GFP Nanobody by Country
7.1.1 Europe Anti-GFP Nanobody Sales by Country (2019-2024)
7.1.2 Europe Anti-GFP Nanobody Revenue by Country (2019-2024)
7.2 Europe Anti-GFP Nanobody Sales by Type (2019-2024)
7.3 Europe Anti-GFP Nanobody Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-GFP Nanobody by Country
8.1.1 Middle East & Africa Anti-GFP Nanobody Sales by Country (2019-2024)
8.1.2 Middle East & Africa Anti-GFP Nanobody Revenue by Country (2019-2024)
8.2 Middle East & Africa Anti-GFP Nanobody Sales by Type (2019-2024)
8.3 Middle East & Africa Anti-GFP Nanobody Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-GFP Nanobody
10.3 Manufacturing Process Analysis of Anti-GFP Nanobody
10.4 Industry Chain Structure of Anti-GFP Nanobody
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-GFP Nanobody Distributors
11.3 Anti-GFP Nanobody Customer
12 WORLD FORECAST REVIEW FOR ANTI-GFP NANOBODY BY GEOGRAPHIC REGION
12.1 Global Anti-GFP Nanobody Market Size Forecast by Region
12.1.1 Global Anti-GFP Nanobody Forecast by Region (2025-2030)
12.1.2 Global Anti-GFP Nanobody Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Anti-GFP Nanobody Forecast by Type (2025-2030)
12.7 Global Anti-GFP Nanobody Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Sino Biological
13.1.1 Sino Biological Company Information
13.1.2 Sino Biological Anti-GFP Nanobody Product Portfolios and Specifications
13.1.3 Sino Biological Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sino Biological Main Business Overview
13.1.5 Sino Biological Latest Developments
13.2 GenScript
13.2.1 GenScript Company Information
13.2.2 GenScript Anti-GFP Nanobody Product Portfolios and Specifications
13.2.3 GenScript Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GenScript Main Business Overview
13.2.5 GenScript Latest Developments
13.3 Proteintech Group
13.3.1 Proteintech Group Company Information
13.3.2 Proteintech Group Anti-GFP Nanobody Product Portfolios and Specifications
13.3.3 Proteintech Group Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Proteintech Group Main Business Overview
13.3.5 Proteintech Group Latest Developments
13.4 Abiocenter
13.4.1 Abiocenter Company Information
13.4.2 Abiocenter Anti-GFP Nanobody Product Portfolios and Specifications
13.4.3 Abiocenter Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Abiocenter Main Business Overview
13.4.5 Abiocenter Latest Developments
13.5 MerryBio
13.5.1 MerryBio Company Information
13.5.2 MerryBio Anti-GFP Nanobody Product Portfolios and Specifications
13.5.3 MerryBio Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 MerryBio Main Business Overview
13.5.5 MerryBio Latest Developments
13.6 Pregene
13.6.1 Pregene Company Information
13.6.2 Pregene Anti-GFP Nanobody Product Portfolios and Specifications
13.6.3 Pregene Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Pregene Main Business Overview
13.6.5 Pregene Latest Developments
13.7 Cusabio
13.7.1 Cusabio Company Information
13.7.2 Cusabio Anti-GFP Nanobody Product Portfolios and Specifications
13.7.3 Cusabio Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Cusabio Main Business Overview
13.7.5 Cusabio Latest Developments
13.8 Biocytogen
13.8.1 Biocytogen Company Information
13.8.2 Biocytogen Anti-GFP Nanobody Product Portfolios and Specifications
13.8.3 Biocytogen Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Biocytogen Main Business Overview
13.8.5 Biocytogen Latest Developments
13.9 Thermo Fisher Scientific
13.9.1 Thermo Fisher Scientific Company Information
13.9.2 Thermo Fisher Scientific Anti-GFP Nanobody Product Portfolios and Specifications
13.9.3 Thermo Fisher Scientific Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Thermo Fisher Scientific Main Business Overview
13.9.5 Thermo Fisher Scientific Latest Developments
13.10 QVQuality
13.10.1 QVQuality Company Information
13.10.2 QVQuality Anti-GFP Nanobody Product Portfolios and Specifications
13.10.3 QVQuality Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 QVQuality Main Business Overview
13.10.5 QVQuality Latest Developments
13.11 HUABIO
13.11.1 HUABIO Company Information
13.11.2 HUABIO Anti-GFP Nanobody Product Portfolios and Specifications
13.11.3 HUABIO Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 HUABIO Main Business Overview
13.11.5 HUABIO Latest Developments
13.12 Jackson ImmunoResearch
13.12.1 Jackson ImmunoResearch Company Information
13.12.2 Jackson ImmunoResearch Anti-GFP Nanobody Product Portfolios and Specifications
13.12.3 Jackson ImmunoResearch Anti-GFP Nanobody Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Jackson ImmunoResearch Main Business Overview
13.12.5 Jackson ImmunoResearch Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Anti-GFP Nanobody Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Anti-GFP Nanobody Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Monovalent Nanobodies
Table 4. Major Players of Bivalent Nanobodies
Table 5. Major Players of Bispecific Nanobodies
Table 6. Major Players of Multivalent Nanobodies
Table 7. Major Players ofFused Nanobodies
Table 8. Global Anti-GFP Nanobody Sales byType (2019-2024) & (K Units)
Table 9. Global Anti-GFP Nanobody Sales Market Share byType (2019-2024)
Table 10. Global Anti-GFP Nanobody Revenue byType (2019-2024) & ($ million)
Table 11. Global Anti-GFP Nanobody Revenue Market Share byType (2019-2024)
Table 12. Global Anti-GFP Nanobody Sale Price byType (2019-2024) & (US$/Unit)
Table 13. Global Anti-GFP Nanobody Sale by Application (2019-2024) & (K Units)
Table 14. Global Anti-GFP Nanobody Sale Market Share by Application (2019-2024)
Table 15. Global Anti-GFP Nanobody Revenue by Application (2019-2024) & ($ million)
Table 16. Global Anti-GFP Nanobody Revenue Market Share by Application (2019-2024)
Table 17. Global Anti-GFP Nanobody Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global Anti-GFP Nanobody Sales by Company (2019-2024) & (K Units)
Table 19. Global Anti-GFP Nanobody Sales Market Share by Company (2019-2024)
Table 20. Global Anti-GFP Nanobody Revenue by Company (2019-2024) & ($ millions)
Table 21. Global Anti-GFP Nanobody Revenue Market Share by Company (2019-2024)
Table 22. Global Anti-GFP Nanobody Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers Anti-GFP Nanobody Producing Area Distribution and Sales Area
Table 24. Players Anti-GFP Nanobody Products Offered
Table 25. Anti-GFP Nanobody Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Anti-GFP Nanobody Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Anti-GFP Nanobody Sales Market Share Geographic Region (2019-2024)
Table 30. Global Anti-GFP Nanobody Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Anti-GFP Nanobody Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Anti-GFP Nanobody Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Anti-GFP Nanobody Sales Market Share by Country/Region (2019-2024)
Table 34. Global Anti-GFP Nanobody Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Anti-GFP Nanobody Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Anti-GFP Nanobody Sales by Country (2019-2024) & (K Units)
Table 37. Americas Anti-GFP Nanobody Sales Market Share by Country (2019-2024)
Table 38. Americas Anti-GFP Nanobody Revenue by Country (2019-2024) & ($ millions)
Table 39. Americas Anti-GFP Nanobody Sales byType (2019-2024) & (K Units)
Table 40. Americas Anti-GFP Nanobody Sales by Application (2019-2024) & (K Units)
Table 41. APAC Anti-GFP Nanobody Sales by Region (2019-2024) & (K Units)
Table 42. APAC Anti-GFP Nanobody Sales Market Share by Region (2019-2024)
Table 43. APAC Anti-GFP Nanobody Revenue by Region (2019-2024) & ($ millions)
Table 44. APAC Anti-GFP Nanobody Sales byType (2019-2024) & (K Units)
Table 45. APAC Anti-GFP Nanobody Sales by Application (2019-2024) & (K Units)
Table 46. Europe Anti-GFP Nanobody Sales by Country (2019-2024) & (K Units)
Table 47. Europe Anti-GFP Nanobody Revenue by Country (2019-2024) & ($ millions)
Table 48. Europe Anti-GFP Nanobody Sales byType (2019-2024) & (K Units)
Table 49. Europe Anti-GFP Nanobody Sales by Application (2019-2024) & (K Units)
Table 50. Middle East & Africa Anti-GFP Nanobody Sales by Country (2019-2024) & (K Units)
Table 51. Middle East & Africa Anti-GFP Nanobody Revenue Market Share by Country (2019-2024)
Table 52. Middle East & Africa Anti-GFP Nanobody Sales byType (2019-2024) & (K Units)
Table 53. Middle East & Africa Anti-GFP Nanobody Sales by Application (2019-2024) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Anti-GFP Nanobody
Table 55. Key Market Challenges & Risks of Anti-GFP Nanobody
Table 56. Key IndustryTrends of Anti-GFP Nanobody
Table 57. Anti-GFP Nanobody Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Anti-GFP Nanobody Distributors List
Table 60. Anti-GFP Nanobody Customer List
Table 61. Global Anti-GFP Nanobody SalesForecast by Region (2025-2030) & (K Units)
Table 62. Global Anti-GFP Nanobody RevenueForecast by Region (2025-2030) & ($ millions)
Table 63. Americas Anti-GFP Nanobody SalesForecast by Country (2025-2030) & (K Units)
Table 64. Americas Anti-GFP Nanobody Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 65. APAC Anti-GFP Nanobody SalesForecast by Region (2025-2030) & (K Units)
Table 66. APAC Anti-GFP Nanobody Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 67. Europe Anti-GFP Nanobody SalesForecast by Country (2025-2030) & (K Units)
Table 68. Europe Anti-GFP Nanobody RevenueForecast by Country (2025-2030) & ($ millions)
Table 69. Middle East & Africa Anti-GFP Nanobody SalesForecast by Country (2025-2030) & (K Units)
Table 70. Middle East & Africa Anti-GFP Nanobody RevenueForecast by Country (2025-2030) & ($ millions)
Table 71. Global Anti-GFP Nanobody SalesForecast byType (2025-2030) & (K Units)
Table 72. Global Anti-GFP Nanobody RevenueForecast byType (2025-2030) & ($ millions)
Table 73. Global Anti-GFP Nanobody SalesForecast by Application (2025-2030) & (K Units)
Table 74. Global Anti-GFP Nanobody RevenueForecast by Application (2025-2030) & ($ millions)
Table 75. Sino Biological Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 76. Sino Biological Anti-GFP Nanobody Product Portfolios and Specifications
Table 77. Sino Biological Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sino Biological Main Business
Table 79. Sino Biological Latest Developments
Table 80. GenScript Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 81. GenScript Anti-GFP Nanobody Product Portfolios and Specifications
Table 82. GenScript Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. GenScript Main Business
Table 84. GenScript Latest Developments
Table 85. Proteintech Group Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 86. Proteintech Group Anti-GFP Nanobody Product Portfolios and Specifications
Table 87. Proteintech Group Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Proteintech Group Main Business
Table 89. Proteintech Group Latest Developments
Table 90. Abiocenter Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 91. Abiocenter Anti-GFP Nanobody Product Portfolios and Specifications
Table 92. Abiocenter Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Abiocenter Main Business
Table 94. Abiocenter Latest Developments
Table 95. MerryBio Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 96. MerryBio Anti-GFP Nanobody Product Portfolios and Specifications
Table 97. MerryBio Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. MerryBio Main Business
Table 99. MerryBio Latest Developments
Table 100. Pregene Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 101. Pregene Anti-GFP Nanobody Product Portfolios and Specifications
Table 102. Pregene Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Pregene Main Business
Table 104. Pregene Latest Developments
Table 105. Cusabio Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 106. Cusabio Anti-GFP Nanobody Product Portfolios and Specifications
Table 107. Cusabio Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Cusabio Main Business
Table 109. Cusabio Latest Developments
Table 110. Biocytogen Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 111. Biocytogen Anti-GFP Nanobody Product Portfolios and Specifications
Table 112. Biocytogen Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Biocytogen Main Business
Table 114. Biocytogen Latest Developments
Table 115.ThermoFisher Scientific Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 116.ThermoFisher Scientific Anti-GFP Nanobody Product Portfolios and Specifications
Table 117.ThermoFisher Scientific Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118.ThermoFisher Scientific Main Business
Table 119.ThermoFisher Scientific Latest Developments
Table 120. QVQuality Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 121. QVQuality Anti-GFP Nanobody Product Portfolios and Specifications
Table 122. QVQuality Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. QVQuality Main Business
Table 124. QVQuality Latest Developments
Table 125. HUABIO Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 126. HUABIO Anti-GFP Nanobody Product Portfolios and Specifications
Table 127. HUABIO Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. HUABIO Main Business
Table 129. HUABIO Latest Developments
Table 130. Jackson ImmunoResearch Basic Information, Anti-GFP Nanobody Manufacturing Base, Sales Area and Its Competitors
Table 131. Jackson ImmunoResearch Anti-GFP Nanobody Product Portfolios and Specifications
Table 132. Jackson ImmunoResearch Anti-GFP Nanobody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Jackson ImmunoResearch Main Business
Table 134. Jackson ImmunoResearch Latest Developments
LIST OFFIGURES
Figure 1. Picture of Anti-GFP Nanobody
Figure 2. Anti-GFP Nanobody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-GFP Nanobody Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Anti-GFP Nanobody Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Anti-GFP Nanobody Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Anti-GFP Nanobody Sales Market Share by Country/Region (2023)
Figure 10. Anti-GFP Nanobody Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Monovalent Nanobodies
Figure 12. Product Picture of Bivalent Nanobodies
Figure 13. Product Picture of Bispecific Nanobodies
Figure 14. Product Picture of Multivalent Nanobodies
Figure 15. Product Picture ofFused Nanobodies
Figure 16. Global Anti-GFP Nanobody Sales Market Share byType in 2023
Figure 17. Global Anti-GFP Nanobody Revenue Market Share byType (2019-2024)
Figure 18. Anti-GFP Nanobody Consumed in Immunoprecipitation
Figure 19. Global Anti-GFP Nanobody Market: Immunoprecipitation (2019-2024) & (K Units)
Figure 20. Anti-GFP Nanobody Consumed in Chromatin Immunoprecipitation
Figure 21. Global Anti-GFP Nanobody Market: Chromatin Immunoprecipitation (2019-2024) & (K Units)
Figure 22. Anti-GFP Nanobody Consumed in RNA Binding Protein Immunoprecipitation
Figure 23. Global Anti-GFP Nanobody Market: RNA Binding Protein Immunoprecipitation (2019-2024) & (K Units)
Figure 24. Anti-GFP Nanobody Consumed in Other
Figure 25. Global Anti-GFP Nanobody Market: Other (2019-2024) & (K Units)
Figure 26. Global Anti-GFP Nanobody Sale Market Share by Application (2023)
Figure 27. Global Anti-GFP Nanobody Revenue Market Share by Application in 2023
Figure 28. Anti-GFP Nanobody Sales by Company in 2023 (K Units)
Figure 29. Global Anti-GFP Nanobody Sales Market Share by Company in 2023
Figure 30. Anti-GFP Nanobody Revenue by Company in 2023 ($ millions)
Figure 31. Global Anti-GFP Nanobody Revenue Market Share by Company in 2023
Figure 32. Global Anti-GFP Nanobody Sales Market Share by Geographic Region (2019-2024)
Figure 33. Global Anti-GFP Nanobody Revenue Market Share by Geographic Region in 2023
Figure 34. Americas Anti-GFP Nanobody Sales 2019-2024 (K Units)
Figure 35. Americas Anti-GFP Nanobody Revenue 2019-2024 ($ millions)
Figure 36. APAC Anti-GFP Nanobody Sales 2019-2024 (K Units)
Figure 37. APAC Anti-GFP Nanobody Revenue 2019-2024 ($ millions)
Figure 38. Europe Anti-GFP Nanobody Sales 2019-2024 (K Units)
Figure 39. Europe Anti-GFP Nanobody Revenue 2019-2024 ($ millions)
Figure 40. Middle East & Africa Anti-GFP Nanobody Sales 2019-2024 (K Units)
Figure 41. Middle East & Africa Anti-GFP Nanobody Revenue 2019-2024 ($ millions)
Figure 42. Americas Anti-GFP Nanobody Sales Market Share by Country in 2023
Figure 43. Americas Anti-GFP Nanobody Revenue Market Share by Country (2019-2024)
Figure 44. Americas Anti-GFP Nanobody Sales Market Share byType (2019-2024)
Figure 45. Americas Anti-GFP Nanobody Sales Market Share by Application (2019-2024)
Figure 46. United States Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 47. Canada Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 48. Mexico Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 49. Brazil Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 50. APAC Anti-GFP Nanobody Sales Market Share by Region in 2023
Figure 51. APAC Anti-GFP Nanobody Revenue Market Share by Region (2019-2024)
Figure 52. APAC Anti-GFP Nanobody Sales Market Share byType (2019-2024)
Figure 53. APAC Anti-GFP Nanobody Sales Market Share by Application (2019-2024)
Figure 54. China Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 55. Japan Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 56. South Korea Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 57. Southeast Asia Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 58. India Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 59. Australia Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 60. ChinaTaiwan Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 61. Europe Anti-GFP Nanobody Sales Market Share by Country in 2023
Figure 62. Europe Anti-GFP Nanobody Revenue Market Share by Country (2019-2024)
Figure 63. Europe Anti-GFP Nanobody Sales Market Share byType (2019-2024)
Figure 64. Europe Anti-GFP Nanobody Sales Market Share by Application (2019-2024)
Figure 65. Germany Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 66.France Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 67. UK Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 68. Italy Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 69. Russia Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 70. Middle East & Africa Anti-GFP Nanobody Sales Market Share by Country (2019-2024)
Figure 71. Middle East & Africa Anti-GFP Nanobody Sales Market Share byType (2019-2024)
Figure 72. Middle East & Africa Anti-GFP Nanobody Sales Market Share by Application (2019-2024)
Figure 73. Egypt Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 74. South Africa Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 75. Israel Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 76.Turkey Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 77. GCC Countries Anti-GFP Nanobody Revenue Growth 2019-2024 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Anti-GFP Nanobody in 2023
Figure 79. Manufacturing Process Analysis of Anti-GFP Nanobody
Figure 80. Industry Chain Structure of Anti-GFP Nanobody
Figure 81. Channels of Distribution
Figure 82. Global Anti-GFP Nanobody Sales MarketForecast by Region (2025-2030)
Figure 83. Global Anti-GFP Nanobody Revenue Market ShareForecast by Region (2025-2030)
Figure 84. Global Anti-GFP Nanobody Sales Market ShareForecast byType (2025-2030)
Figure 85. Global Anti-GFP Nanobody Revenue Market ShareForecast byType (2025-2030)
Figure 86. Global Anti-GFP Nanobody Sales Market ShareForecast by Application (2025-2030)
Figure 87. Global Anti-GFP Nanobody Revenue Market ShareForecast by Application (2025-2030)
